Wilbur James
SEC CIK 1940931 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TXG | 10x Genomics, Inc. | Chief Commercial Off | 83.3K | — | $1.23M | 6 | 2022-09-14 | 2023-11-22 |
Most active insiders at TXG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Saxonov Serge | CEO, Dir | — | $6.82M |
| 2 | Taich Adam | CFO | — | $4.84M |
| 3 | STUELPNAGEL JOHN R | Dir | — | $2.39M |
| 4 | Hindson Benjamin J. | See Remarks, Dir | — | $1.46M |
| 5 | SULIMAN SHEHNAAZ | Dir | — | $791.9K |
| 6 | Teichmann Sarah A. | Dir | — | $579.4K |
| 7 | Kosaraju Sridhar | Dir | — | — |
| 8 | MATEO ALAN | Dir | — | — |
| 9 | Popovits Kimberly J | Dir | — | — |
Wilbur James made no open-market trades at TXG in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-27 | 2023-11-22 | TXG | 10x Genomics, Inc. | Wilbur James | Chief Commercial Off | S - Sale | $43.34 | -3,464 | 83.3K | -4% | -$150.1K | |
| 2023-11-22 | 2023-11-20 | TXG | 10x Genomics, Inc. | Wilbur James | Chief Commercial Off | S - Sale | $42.09 | -14.7K | 86.8K | -14% | -$619.5K | |
| 2023-08-24 | 2023-08-22 | TXG | 10x Genomics, Inc. | Wilbur James | Chief Commercial Off | S - Sale | $45.78 | -9,699 | 101.3K | -9% | -$444.0K | |
| 2023-05-25 | 2023-05-23 | TXG | 10x Genomics, Inc. | Wilbur James | Chief Commercial Off | S - Sale | $55.07 | -316 | 111.0K | -0.3% | -$17.4K | |
| D | 2023-03-23 | 2023-03-21 | TXG | 10x Genomics, Inc. | Wilbur James | Chief Commercial Off | A - Grant | $0.00 | +14.6K | 110.4K | +15% | $0 |
| D | 2022-09-16 | 2022-09-14 | TXG | 10x Genomics, Inc. | Wilbur James | Chief Commercial Off | A - Grant | $0.00 | +95.8K | 95.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations